% Expired Patents = 80.0

CIPO Patents = 1

EPO Patents = 2

Forward Citations = 0

Loading Chart...

7 inventors (with patents filed for the assignee):

Isabel Kalofonos (5 out of 6 patents)

William Martin-Doyle (5 out of 6 patents)

G Patrick Stahly (4 out of 19 patents)

4. Travis Lee Houston (4 out of 26 patents)

5. Dimitris Kalofonos (4 out of 12 patents)

6. Jeffrey S Stults (4 out of 35 patents)

7. Judy Caron (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 10464912 - Choline cocrystal of epalrestat (2019-11-05),

2. 9611234 - Choline cocrystal of epalrestat (2017-04-04),

3. 9566269 - Modified release compositions of epalrestat or a derivative thereof and methods for using the same (2017-02-14),

4. 9447056 - Solid forms of epalrestat (2016-09-20),

5. 8697735 - Solid forms of epalrestat (2014-04-15),

Company Overview

Bionevia Pharmaceuticals, Inc. is a leading biopharmaceutical company dedicated to discovering and developing innovative therapies for various diseases. With a focus on research and development, Bionevia is committed to improving the lives of patients through novel treatments and advancements in healthcare.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#368 in Cambridge, MA

#2,892 in Massachusetts

#51,570 in US

Cambridge, MA, United States of America

Bionevia Pharmaceuticals, Inc.

Forward Citations = 0

7 inventors:

Isabel Kalofonos (5 out of 6 patents)

William Martin-Doyle (5 out of 6 patents)

G Patrick Stahly (4 out of 19 patents)

4. Travis Lee Houston (4 out of 26 patents)

5. Dimitris Kalofonos (4 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bionevia Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/bionevia-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]